Neo-adjuvant Immunotherapy in Patients With Localized Melanoma

Clinical trial NCT07230613 · RECRUITING

Trial details

NCT number: NCT07230613
Sponsor: UNICANCER
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Melanoma, Stage III Mucosal Melanoma

Start date: 2026-01-12
Primary completion: 2027-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.